Modelling Survival Data in Medical Research

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

Yang, J. C.-H., Wu, Y.-L., Schuler, M., Sebastian, M., Popat, S., Yamamoto, N., Zhou, C., Hu, C.-P., O'Byrne, K., Feng, J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71173-8 · Cited by 1,574

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

Richardson, P. G., Weller, E., Lonial, S., Jakubowiak, A. J., Jagannath, S., Raje, N. S., Avigan, D. E., Xie, W., Ghobrial, I. M., Schlossman, R. L., et al. (2010) · Blood · doi:10.1182/blood-2010-02-268862 · Cited by 861

Timing of identification among children with an autism spectrum disorder: findings from a population-based surveillance study

Shattuck, P. T., Durkin, M., Maenner, M., Newschaffer, C., Mandell, D. S., Wiggins, L., Lee, L.-C., Rice, C., Giarelli, E., Kirby, R., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819b3848 · Cited by 623

Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials

Dobson, J., Whitley, R. J., Pocock, S., & Monto, A. S. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62449-1 · Cited by 594

The starvation hormone, fibroblast growth factor-21, extends lifespan in mice

Zhang, Y., Xie, Y., Berglund, E. D., Coate, K. C., He, T. T., Katafuchi, T., Xiao, G., Potthoff, M. J., Wei, W., Wan, Y., et al. (2012) · eLife · doi:10.7554/elife.00065 · Cited by 420

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma

Mikhaeel, N. G., Hutchings, M., Fields, P. A., O'Doherty, M. J., & Timothy, A. R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi272 · Cited by 401

Elevated levels of tumor necrosis factor alpha and mortality in centenarians

Bruunsgaard, H., Andersen-Ranberg, K., Hjelmborg, J. V. B., Pedersen, B. K., & Jeune, B. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00329-2 · Cited by 325

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

Rajamani, K., Colman, P. G., Li, L. P., Best, J. D., Voysey, M., D'Emden, M. C., Laakso, M., Baker, J. R., & Keech, A. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60698-x · Cited by 328

Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma

Massanari, M., Nelson, H., Casale, T., Busse, W., Kianifard, F., Geba, G. P., & Zeldin, R. K. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.11.022 · Cited by 230

Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients.

Xie, Y., Xiao, G., Coombes, K. R., Behrens, C., Solis, L. M., Raso, G., Girard, L., Erickson, H. S., Roth, J., Heymach, J. V., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0196 · Cited by 162

Evaluation of the increase in model for end-stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child–Turcotte–Pugh score

Huo, T.-I., Wu, J.-C., Lin, H.-C., Lee, F.-Y., Hou, M.-C., Lee, P.-C., Chang, F.-Y., & Lee, S.-D. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.01.019 · Cited by 143

Incidence of Remission in Adults With Type 2 Diabetes: The Diabetes & Aging Study

Karter, A. J., Nundy, S., Parker, M. M., Moffet, H. H., & Huang, E. S. (2014) · Diabetes Care · doi:10.2337/dc14-0874 · Cited by 132

Mortality after discharge from acute care hospitalization with traumatic brain injury: A population-based study

Ventura, T., Harrison-Felix, C., Carlson, N., DiGuiseppi, C., Gabella, B., Brown, A., DeVivo, M., & Whiteneck, G. (2010) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2009.08.151 · Cited by 125

Association of C-Reactive Protein With Cardiovascular Disease Mortality According to Diabetes Status

Kengne, A. P., Batty, G. D., Hamer, M., Stamatakis, E., & Czernichow, S. (2012) · Diabetes Care · doi:10.2337/dc11-1588 · Cited by 105

Dietary glycemic index, dietary glycemic load, and cardiovascular disease in middle-aged and older Swedish men

Levitan, E. B., Mittleman, M. A., Håkansson, N., & Wolk, A. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.6.1521 · Cited by 100

Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial

Bonnett, L., Smith, C. T., Smith, D., Williamson, P., Chadwick, D., & Marson, A. G. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70018-2 · Cited by 69

Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer

Eatock, M. M., Tebbutt, N. C., Bampton, C. L., Strickland, A. H., Valladares-Ayerbes, M., Swieboda-Sadlej, A., Van Cutsem, E., Nanayakkara, N., Sun, Y.-N., Zhong, Z. D., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds502 · Cited by 64

Association of Temporal Variations in Staffing With Hospital‐Acquired Pressure Injury in Military Hospitals

Patrician, P. A., McCarthy, M. S., Swiger, P., Raju, D., Breckenridge‐Sproat, S., Su, X., Randall, K. H., & Loan, L. A. (2017) · Research in Nursing & Health · doi:10.1002/nur.21781 · Cited by 15